General Pathology
Theme 8: Tissue Healing and Repair
- Appreciate the relationship between Cellular Growth, Fibrosis and Wound Healing.
- Describe the process and outcome of regeneration.
- Describe the process and outcome of fibrous connective tissue repair.
- List the factors that influence wound healing and describe the possible complications.
- Present an overview of the inflammatory-reparative response.
- Discuss the clinico-pathological consequences of damage and healing in specific
tissues: liver, kidney, lung, heart, nervous system and bone.
| Cell Types and Regenerative Ability |
Labile Cells
Cells with a short lifespan that constantly proliferate
and are lost from the body: skin, gut, hematopoetic cells. Cells have
short G0 (resting, or intermitotic) phase. Continued loss of mature
cells is a continuous stimulus for resting cells to enter the mitotic cell
cycle.
Permanent Cells
Cells that cannot regenerate once they are
destroyed. A destroyed cell will form a scar. Brain, Heart. Cells exit
the cell cycle and cannot regenerate.
Stable Cells
Cells that have a long lifespan and a very low rate of
division. They remain in G0 phase of the
cell-cycle for long periods and don't normally divide, but can enter the mitotic
cycle and be induced to divide quickly upon
injury. These cells have good regenerative capacity. Liver, Renal proximal
convoluted tubule. Unlike labile cells, which are undifferentiated cells
that divide frequently and must undergo maturation before becoming functional,
stable cells are differentiated functional cells that only revert to a dividing
mode at need. Such cells heal by regeneration when (1) enough viable
tissue remain to regenerate; (2) connective tissue framework is intact. When
necrosis of both the parenchyma and connective tissue framework occurs (e.g.
renal infarct), no regeneration is possible and healing occurs by scar
formation.
- Acute Tubular Necrosis occurs with
O2-deprivation in O2-hungry renal tubules. As long as the
basement membrane is intact (i.e. tissue framework present), the tubule cells will regenerate.
- Oliguric Phase: Little urine output during necrosis --
kidney shuts down.
- Polyuric Phase: Lots of output during healing process.
Kidney functions but the proximal tubules are busy regenerating, thus
reabsorption is very low.
| Role of Glycoproteins and Proteoglycans |
The extracellular matrix (ECM) consists of the materials over which cells migrate and travel during development and wound-healing. They are:
Collagen
There are four types of collagen we need to know. Collagen is synthesized and secreted by fibroblasts.
- TYPE I Collagen: Skin,, bone, and tendon.
- TYPE II Collagen: Cartilege.
- TYPE III Collagen: Aorta, uterus, and GI smooth muscle. Reticular collagen.
- TYPE IV Collagen: Basement membranes, exclusively.
- Scleroderma is proliferation of collagen.
- Cross-linking (which strengthens fibrils) of collagen fibrils require vitamin C.
Basement Membrane
Made of Type IV Collagen.
- Synthesized by basal cells of epithelia.
- Function: Filtration in the kidney. Basement membrane contains heparin sulfate, which is negatively charged, to guide filtration and keep out big negatively charged proteins like albumin.
Elastic Fibres
Elastin provides tissues with elasticity or the ability to stretch and recoil.
- Found in pliable structures like arteries and uterus.
- Similar to collagen (containing Pro and Lys), but contains almost no hydroxylated structures (thus cross-linking limited).
- Marfan Syndrome is a defect in elastic fibers.
Glycoproteins
- Fibronectin
- Binds to several ECM components (collagen, heparin, fibrin, proteoglycans) on one hand and to cell membranes on the other.
- Thus, fibronectin is directly involved in cell attachment, spreading and locomotion and interacts with growth factors to affect growth and differentiation. (i.e. functions as a guide, to
assist cells to migrate through the matrix.)
-
Wound Healing: Fibronectin plays an important cross-linking function.
- Laminin, a cross-shaped glycoprotein spanning basement membranes, also binds to cells through specific receptors and to collagen type IV and heparin and is involved in cell attachment, locomotion, and growth.
- Matricellular Proteins are secreted proteins that do not function as structural components of the ECM. These proteins interact with matrix components, cell surface receptors, or other molecules (e.g., growth factors, cytokines, or proteases), which interact, in turn, with the cell surface. The group shares the ability to disrupt cell-matrix interactions. This family of versatile adapter proteins includes SPARC
(secreted protein acidic and rich in cysteine, also known as osteonectin), the thrombospondins, osteopontin, and the tenascin family members.
Integrins
Transmembrane proteins that interact with the ECM. They may act as a
communication link between intracellular environment and extracellular matrix.
Via integrins, the ECM can modify cell behavior. Integrins are the major family of cell surface receptors that mediate cellular attachment to the ECM. Many integrins are widely expressed, and most cells have more than one integrin on the cell surface. Integrin receptors span the cell membrane and bind to many components (e.g., fibronectin, laminin, and some collagens) of the ECM. Integrin receptors are important both in organizing the actin cytoskeleton of cells at points of focal adhesion and in transduction of signals from the ECM to the cell interior. The mechanical linkage between the integrin receptors and the cytoskeletal signaling system may be a mechanism by which cells convert mechanical force into biochemical signals.
Proteoglycans and Hyaluronan
Proteoglycans are ECM components that consist of a core protein linked to one or more polysaccharides called glycosaminoglycans. Olycosaminoglycans are long repeating polymers of modified disaccharides (e.g., heparan sulfate). Proteoglycans can also be integral membrane proteins, as in the syndecan family, in which the core protein spans the plasma membrane.
Hyaluronan is a huge molecule consisting of many repeats of a disaccharide. It serves as a ligand for core proteins and cell surface receptors. Hyaluronan binds large amounts of water, which helps give connective tissue turgor pressure and the ability to resist compression forces.
Tissue injuries associated with inflammation are eventually followed by some
form of healing. Resolution is the ideal result of healing where
the tissue is restored to the normal (pre-injury) state. After removal of
cellular debris associated with the inflammation, any necrotic parenchymal cells
are replaced by new parenchymal cells of the same type in a process known as regeneration.
When resolution and regeneration are not possible, necrotic cells are replaced with collagen in a process called organisation, or repair by scar formation.
Replacement of lost parenchymal cells by division of adjacent surviving cells
(regeneration) can restore injured tissue to normal. This depends on:
- regenerative capacity of involved cells.
- number of surviving viable cells.
- presence of a connective tissue framework that will provide a base for restoration of normal tissue structure.
Before regeneration can occur, necrotic cells must be removed. This involves an acute inflammatory response,
liquefaction of cells by neutrophil enzymes and removal of debris by lymphatics and macrophages.
| Organisation, Repair by Scar Formation |
As tissue destruction in wound healing and chronic inflammation involves both parenchymal cells and the stromal framework, repair cannot be accomplished solely by regeneration of parenchymal cells. Repair thus involves in large part the
replacement of lost cells and tissues by connective tissue, which, in time, produces fibrosis and scarring. Connective tissue repair is the systematic processes by which unregenerated damage is replaced by fibrosis and scarring. The initial response to a wound consists of the formation of
Granulation tissue, which consists of a richly vascular connective tissue, containing new capillaries, proliferating fibroblasts, and variable numbers of
inflammatory cells. (Note: Granulation tissue must be distinguished from
granuloma, which is an aggregate of macrophages associated with chronic
inflammation.)
There are four components to this orderly process:
- Formation of new blood vessels (angiogenesis), spanning the wound;
- Migration and proliferation of fibroblasts filling and bridging the wound;
- Deposition of ECM and;
- Maturation and reorganization of the fibrous tissue into a scar, also known as remodeling.
Angiogenesis
Angiogenesis is critical for chronic inflammation, formation of collateral circulation, and tumor growth. Blood vessels are assembled by two processes:
- Vasculogenesis, in which a primitive vascular network is assembled during development, and;
- Angiogenesis (or neovascularization), in which preexisting blood vessels give rise to capillary buds to produce new vessels.
Fibroblast Growth Factor (FGF) is a cytokine that is
thought to induce angiogenesis.
Multiple steps underlie angiogenesis:
- proteolytic degradation of the basement membrane of the parent vessel basement membrane;
- endothelial cell migration and formation of a capillary sprout;
- proliferation and maturation of endothelial cells, which includes remodeling into capillary tubes; and recruitment of periendothelial cells, including pericytes for small capillaries and vascular smooth muscle cells for larger vessels to support the endothelial tubes.
The formation, maintenance, and remodeling of blood vessels are controlled by the following:
- Growth factors and receptors: Many growth factors have angiogenic activity, but VEGF and the angiopoietins (Ang) are particularly important in establishing and maintaining new blood vessels. They interact with the corresponding tyrosine kinase receptors (VEGF-R and Tie) uniquely expressed by endothelial cells. PDGF and its receptors are important in recruiting periendothelial cells.
- ECM proteins, as regulators of angiogenesis: The cell motility and directed migration of endothelial cells that occurs during angiogenesis is regulated by integrins, matricellular proteins (e.g., SPARC), and proteases (e.g., plasminogen activators and matrix metalloproteases).
- Angiogenesis inhibitors: These act to down-regulate new vessel growth and include certain cytokines (e.g., interferon-a); tissue inhibitors of metalloproteinases; certain matricellular proteins (e.g., thrombospondin); and tumor-derived factors, such as angiostatin (a fragment of plasminogen) and endostatin (a fragment of collagen).
Fibrosis (Fibroplasia)
Fibrosis occurs within the granulation tissue framework formed at the site of repair and involves two processes:
- Fibroblast migration and proliferation: Increased vascular permeability leads to the deposition of plasma proteins, such as fibronectin and fibrinogen, which provide a provisional stroma for ingrowth of fibroblasts. Migration of fibroblasts and their subsequent proliferation is also mediated by growth factors such as PDGF, EGF, FGF, and TGF-ß and the fibrogenic cytokines IL-l and TNF-a.
- ECM deposition: As repair progresses, the number of proliferating endothelial cells and fibroblasts decreases. The fibroblasts become more synthetic and deposit increased amounts of collagen and other components of the ECM. Collagen synthesis is stimulated by growth factors (e.g., PDGF, FGF) and by cytokines (e.g., IL-l) secreted by fibroblasts and leukocytes in healing wounds. TGF-ß is thought to play a particularly important role in chronic inflammatory fibrosis. Eventually the granulation tissue scafolding is converted into a scar composed of fibroblasts and collagen.
Tissue Remodelling or Scar Formation
The replacement of granulation tissue with a scar involves transitions in the composition of the ECM. Some of the growth factors that stimulate synthesis of collagen and other connective tissue molecules modulate the synthesis and activation of matrix metalloproteinases (MMPs), enzymes that serve to degrade these ECM components. MMPs consist of interstitial collagenases, which cleave the fibrillar collagen types I, II, and III; gelatinases (or type W collagenases), which degrade amorphous collagen as well as fibronectin; stromelysins, which act on a variety of ECM components, including proteoglycans, laminin, fibronectin, and amorphous collagens; and the family of membrane-bound MMPs, which are cell surface-associated proteases. Secretion of MMPs by fibroblasts and leukocytes is induced by growth factors and cytokines and inhibited by
TGF-ß. The enzymes are secreted as proenzymes, which are activated extracellularly. Activated MMPs can be rapidly inhibited by a family of specific tissue inhibitors of metalloproteinase. The net effect of ECM synthesis versus degradation results in debridement of injured sites and remodeling of the connective tissues framework-important features of both chronic inflammation and wound repair.
Wound healing is a complex but orderly phenomenon involving many of the processes just described:
- Induction of an acute inflammatory process by the initial injury
- Regeneration of parenchymal cells
- Migration and proliferation of both parenchymal and connective tissue cells
- Synthesis of ECM proteins
- Remodeling of connective tissue and parenchymal components
- Collagenizaton and acquisition of wound strength
Healing by First (Primary) Intention
Clean incised wounds and lacterations in which the edges of the wound are in close apposition heal by first intention.
The young scar that becomes visible when the scab separates from the skin is initally pink because of the vascularity of the dermal granulation tissue but over the next few weeks the scar turns white as a result of a decrease in number of blood vessels and an increased amount of collagen in the maturing scar. Eventually the scar assumes normal skin colour as the epidermis matures.
Sequence of events are as follows:
- O hours: The incision is filled with clot.
- 3 to 24 hours: Neutrophils from the margins infiltrate the clot. Mitoses begin to appear in epithelial basal cells; epithelial closure takes place by 24 to 48 hours.
- Day 3: Neutrophils are replaced by macrophages. Granulation tissue begins to appear.
- Day 5: The incision space is filled with granulation tissue, neovascularization is maximal, collagen fibrils begin to appear, and epithelial proliferation is now maximal.
- Week 2: There is proliferation of fibroblasts and continued collagen accumulation to produce a scar. Collagen deposited early in granulation tissue is type III, which is then replaced by adult type I collagen. Collagen fibers account in large part for wound strength. Inflammation and newly formed vessels have largely disappeared.
- Month 2: Scar now consists of connective tissue devoid of inflammation covered by intact epidermis.
Healing by Second (Secondary) Intention
Healing by second intention occurs when there is more extensive loss of tissue, such as:
- lacerations characterized by inability to achieve opposition of wound margins (e.g., uneven cut);
- foreign material is present;
- necrosis is extensive (e.g., infarction, ulceration);
- infection occurs (e.g., abscess formation);
- large wounds.
Abundant granulation tissue grows in from the margins to fill the defect, but at the same time the wound contracts; that is, the defect is markedly reduced from its original size. Myofibroblasts contribute to wound contraction.
Debridement
Surgical removal of dead tissue and foreign material from the wound. This aids healing by clearing away the debris associated with inflammation.
Demolition
- Inflammatory cells localize the injury by sequestration and removal fo the offending agents.
- Walling off the damaged area and elmininating dead tissues through phagocytosis, lymphatic drainage or sloughing, but autolytic enzymes from dead tissue cells and polymorphs.
- Protecting the injury site while repair takes place.
Wound Strength
Tensile strength of the young scar is only about 10% that of normal skin but increases to 30%-50% of normal skin by 4 weeks and to 80% after several months. The latter is associated with first increased collagen synthesis exceeding degradation and subsequently with the cross-linking and increased fiber size of collagen fibres.
| Local and Systemic Factors that Influence Wound Healing |
Local Factors
- Infection
- Poor blood supply (ischaemia)
- Presence of foreign material
- Presence of necrotic tissue
- Movement in injured area
- Irradiation
- Tension in injured area
Systemic Factors
- Advanced age
- Protein malnutrition
- Vitamin C deficiency
- Zinc deficiency
- Obesity leads to poor vascularity and thus poor wound healing
- Race: Dark-skined people (blacks) at higher risk of forming keloids
- Corticosteroid excess
- Decreased numbers of neutrophils or macrophages
- Diabetes mellitus
- Cytotoxic (anticancer) drugs
- Severe anaemia
- Bleeding disorders
- Ehlers-Danlos syndrome
| Pathologic Aspects of Wound Healing |
Complications in wound healing can arise from abnormalities in any of the basic repair processes. These aberrations can be grouped into 3 general categories:
- Deficient scar formation: this can lead to 2 types of complications:
- Wound dehiscence (The bursting of a wound. Failure of tensile strength
of scar)
- Abdominal wounds are the most subject to dehiscence, thus surgeons let abdominal wounds heal by secondary intent.
- Abdominal dehiscence can be provoked by coughing, vomiting, wound infection, or poor nutrition during the healing period.
- Ulceration
- Excessive formation of the repair components: The formation of excessive amounts of granulation tissue, which protrudes above the level of the surrounding skin and blocks
re-epithelialization, has been called exuberant granulation or proud
flesh. The accumulation of excessive amounts of collagen may give rise to a raised tumorous scar known as a
keloid, or hypertrophic scar.
- Formation of contractures: As we have seen, contraction in the size of a wound is an important part in the normal healing process. An exaggeration of this process, as, for example, in the hand or face, is designated a contracture and results in deformities of the wound and the surrounding tissues, producing in the hand claw deformities or limiting the mobility of a joint.
| Clinico-Pathological Consequences of Damage and Healing in Specific Tissues |
Cirrhosis
Result of a chronically damaged liver.
Histologically, it a combination of regenerated liver cells interspersed with
fibrosis.
- Micronodular Cirrhosis: Alcoholic
Cirrhosis. Alcohol kills liver cells globally and destroys basement
membranes (BM). With BM's destroyed, when the liver tries to regenerate, it has no
scaffolding on which to grow, and the result is formation of a bunch of
micronodules, instead of uniform liver tissue.
- Fibrosis runs from Portal Triad to Portal Triad, and works its way inward.
Tissue architecture disrupted, causing higher resistance to blood flow and portal
hypertension.
- Hepatoma: Hepatocellular Carcinoma. Liver tumor occurs more
commonly in cirrhotic livers.
- Because the hepatocytes are constantly proliferating, thus increasing
likelihood of malignancy.
- Concurrent infection with Hepatitis-B or C in alcoholism is extremely
common.
- Macronodular Cirrhosis: Chronic Active
Hepatitis. Nodules form similar to micronodular cirrhosis, except that
injury spreads outward from focal points in the liver -- i.e. from points of
viral infection. The response to this focal injury is formation of nodules which
appear as macronodules.
- Fatty Liver: Reversible damage due to alcohol.
- Alcoholic hyaline is visible with fatty liver.
Cardiac Disease
- Cardiac Tamponade: Blood in the pericardial sac, which can
happen after an myocardial infarction (MI), at the time of maximal healing during formation of
a scar in the myocardial muscle. Rare and instantly fatal.
- Can happen about six days post-MI, during the late phase of healing when
Macrophages are cleaning up debris.
- The ventricular septum can also burst, leading to hypoxia and shock
- Reperfusion Injury by oxidative radicals is a risk after 4
hours post-MI.